Cancer and Thrombosis

dc.contributor.authorDağlı, M.
dc.contributor.authorSivrikaya, A.
dc.date.accessioned2020-03-26T18:32:37Z
dc.date.available2020-03-26T18:32:37Z
dc.date.issued2012
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractVenous thrombosis development is the most important causes of morbidity and mortality in the cases with carcinoma. Besides prevention and treatment of the disease, studies clarifying pathophysiology are required in clinical studies. It is possible to research the initiating factors of forming thrombus in two groups; intravenous and extravenous. Intravenous factors: tissue factors, carcinoma procoagulant, TNF secreted from carcerous cells, IL1, plasminogen activator inhibitor, mucin, thrombomodulus, ADP, heparin sulphat, annexing II can be considered. Extravenous factors are the size of cancerous mass, histopathologic diagnoses, the pressure it causes, vascular wall damage, venous stasis, lengthened immobilization, chemotherapy and surgical interventions. By supporting these factors that contribute to forming thrombosis in the cancer patients with the literature data, treatment choices against the risk of thrombosis will be suggested with the help of guides. © IDOSI Publications, 2012.en_US
dc.identifier.citationDağlı, M., Sivrikaya, A., (2012). Cancer and Thrombosis. World Applied Sciences Journal, 18(4), 543-549.
dc.identifier.doi10.5829/idosi.wasj.2012.18.04.738en_US
dc.identifier.endpage549en_US
dc.identifier.issn1818-4952en_US
dc.identifier.issue4en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage543en_US
dc.identifier.urihttps://dx.doi.org/10.5829/idosi.wasj.2012.18.04.738
dc.identifier.urihttps://hdl.handle.net/20.500.12395/28737
dc.identifier.volume18en_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorDağlı, M.
dc.institutionauthorSivrikaya, A.
dc.language.isoenen_US
dc.relation.ispartofWorld Applied Sciences Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectCanceren_US
dc.subjectDeep Venous Thrombosisen_US
dc.subjectThrombosisen_US
dc.subjectVenous Thromboembolysmen_US
dc.titleCancer and Thrombosisen_US
dc.typeArticleen_US

Dosyalar